Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1

AIM: To evaluate the efficacy and safety of a regimen containing sofosbuvir (SOF) and ledipasvir (LDV) in Japanese patients aged ≥ 75 years with hepatitis C genotype 1. METHODS: This multicenter, retrospective study consisted of 246 Japanese patients with HCV genotype 1 at nine centers in Miyazaki p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozono, Yoshinori, Nagata, Kenji, Hasuike, Satoru, Iwakiri, Hisayoshi, Nakamura, Kenichi, Tsuchimochi, Mai, Yamada, Yuri, Takaishi, Yuka, Sueta, Mitsue, Miike, Tadashi, Tahara, Yoshihiro, Yamamoto, Shojiro, Shide, Kotaro, Hidaka, Tomonori, Kubuki, Yoko, Kusumoto, Kazunori, Ochiai, Toshimasa, Kato, Junya, Komada, Naoto, Hirono, Shuichi, Kuroki, Kazuo, Shigehira, Masafumi, Shimoda, Kazuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756723/
https://www.ncbi.nlm.nih.gov/pubmed/29359017
http://dx.doi.org/10.4254/wjh.v9.i36.1340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756723/
https://www.ncbi.nlm.nih.gov/pubmed/29359017
http://dx.doi.org/10.4254/wjh.v9.i36.1340

Ejemplares similares